Acquisition Announced Sponsor buyer
BC Partners acquisition of Biogaran
Announced Jan 2026 (approx.)
Advisers
Biogaran
Target
Not disclosed
BC Partners
Acquirer
Not disclosed
Other advisers
- Financial adviser
- Target
- Biogaran
- Acquirer
- BC Partners
- Seller
- Servier
- Target based in
- France
- Buyer based in
- United Kingdom
- Seller based in
- France
- Sector
- Pharma
Similar deals
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Gilead acquisition of HCXT-2001 (investigational oral IL-23R inhibitor) Oct 2026 · Pharma
- US WorldMeds acquisition of Orbus Therapeutics Oct 2026 · Pharma
- DRI Healthcare Trust acquisition of Royalty participation rights in U.S. net sales of tavapadon Sep 2026 · US$316m · Specialty finance and leasing
- Grünenthal acquisition of Stivarga (regorafenib) Sep 2026 · US$433m · Pharma
